DFM Platform
DFM Funding Monitor

Pharmaco-modulation of epithelia for induction of antimicrobial peptide expression: a disruptive approach to fight antibiotic resistancebroad

MaxImmun · Horizon Europe grant · 2024-01-01–2027-12-31

EC contribution

€3,194,450

Total cost

€3,194,450

Beneficiaries

7
About the data

Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2023-PATHFINDEROPEN-01 · scheme HORIZON-EIC · topic HORIZON-EIC-2023-PATHFINDEROPEN-01-01. CORDIS record →

Objective

The MaxImmun project aims at preventing and treating infections, and situations of conflict between the host and its microbiota, by developing a disruptive technology based on molecules that boost antimicrobial peptides (AMP) of the innate immune system. To face the problem of antibiotic resistance, this high-potential technology may be relevant both in situations of endemic infections in the developing world, and infectious or inflammatory pathologies in industrialized countries. Our objective is to establish the proof-of-concept that among a series of hit molecules identified for their capacity to promote AMPs, a small subgroup may qualify to lead molecules that can then be pushed into the late phases of the R&D pipeline, with the perspective of a phase I clinical trial. To achieve this transition, our project will range from the comprehension of microbial mechanisms leading to antibiotic resistance, to the comprehension of AMP regulations, the identification of molecules and their optimization by medicinal chemistry, and the characterization and evaluation of their protective efficacy in pre-clinical validation models. Thus, we expect to develop innovative molecules as future antimicrobial drug candidates.

Beneficiaries (7)

OrganisationCountryRoleEC contributionSME
ECOLE NORMALE SUPERIEURE FR coordinator €863,500
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR participant €799,232
HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH DE participant €700,865
UPPSALA UNIVERSITET SE participant €425,000
IRT FR participant €355,875 Yes
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS FR participant €49,978
INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT FR thirdParty €0

Get the EU Defence Funding Calendar — free

The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.

We store your email to send the calendar and the weekly DFM Analysis briefing. Nothing else. Unsubscribe anytime.

Or browse all open defence & dual-use calls on the funding calendar →

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.

DFM Analysis, our free weekly newsletter, tracks the EU defence-funding programmes, calls and decisions behind this page. Subscribe free →